“…These chemokines drive the influx of leukocytes to GVHD target organs, contributing to the inflammatory response ( Serody et al, 2000 ; Terwey et al, 2005 ; Wysocki et al, 2005 ). Thus, our results showing the importance of reducing proinflammatory cytokine and chemokine levels in terms of prevention of fatal GVHD are in agreement with those of previous studies, which proposed an association between reducing the inflammatory response mediated by cytokines and chemokines and GVHD protection after experimental allogeneic hematopoietic stem cell transplant ( Piguet et al, 1987 ; Baker et al, 1996 ; Koide et al, 1997 ; Serody et al, 2000 ; Terwey et al, 2005 ; Wysocki et al, 2005 ; Castor et al, 2010 ; Schroeder and DiPersio, 2011 ; Robb and Hill, 2012 ). In addition, the reduced levels of the chemokines CCL2, CCL3, and CCL5 in zileuton-treated mice may also lead to reduced recruitment of inflammatory cells to target organs.…”